Guo et al reported that IgM antibodies were detectable in 85.4% (35/41) of COVID-19 patients before 7 d PSO [23], and Xiang et al. reported 47.4% (9/19) IgM positivity with samples obtained before 9 d PSO [15]. The gene discussed is CD40LG; the disease is COVID-19.